We surmise that SIRT/PARP1 balance along with activators of SOD2 will provide promising new therapeutic strategies for arresting chronic oxidative and inflammatory stress and cardiac dysfunction in Chagas disease [34]. The gene discussed is PARP1; the disease is Chagas disease.